Januvia gains renal impairment licence in UK
April 13, 2012Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment
Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …
UCB launches ‘Parkinson’s Well-Being Map’
April 13, 2012Medical Communications Parkinson's disease, UCB
UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …
Innovating in China’s pharma market
April 12, 2012Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets
The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …
ViiV Healthcare appoints Just:: Health PR
April 12, 2012Medical Communications, Sales and Marketing HIV/AIDS, Just::, PR, ViiV
ViiV Healthcare has appointed Just:: Health PR to work on an integrated political and public relations initiative that will engage …
Roche on target despite European shrinkage
April 12, 2012Sales and Marketing Illumina, Q1 2012, Roche
Roche saw its business grow in the first three months of the year, thanks to strong showings from hepatitis C …
EMA backs full access to trial data
April 12, 2012Business Services, Research and Development, Sales and Marketing EMA, clinical trial data, data disclosure, regulatory affairs, transparency
The European Medicines Agency says it wants to open up access to full clinical trial data, but warns that some …
immatics appoints Dr Rainer Kramer as its new
 chief business officer
April 12, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
immatics biotechnologies, a biopharma company developing therapeutic cancer vaccines, has appointment Dr Rainer Kramer as its new chief business officer. …
Algeta to co-promote Alpharadin in US
April 12, 2012Sales and Marketing Algeta, Bayer, prostate cancer
Algeta has exercised its option to co-promote Alpharadin for the treatment of cancer patients with bone metastases in the United …
Humira gains European licence for ulcerative colitis
April 11, 2012Sales and Marketing Humira, ulcerative colitis
Abbott’s Humira has gained European approval to treat ulcerative colitis, adding to its six existing licences. It can now …
UK launches ‘biomedical catalyst’ fund
April 11, 2012Biotechnology, SMEs, biomedical catalyst, strategy for life sciences
A £180 million government fund to help innovative small and medium sized enterprises (SMEs) and academics to develop solutions to …
Amgen to acquire kidney disease specialist for $315m
April 11, 2012Sales and Marketing Amgen, KAI Pharmaceuticals
Amgen will acquire KAI Pharmaceuticals for $315 million to bolster its late-stage pipeline. The deal, which should be completed within …
A more ‘nimble approach’ needed for CRO-pharma partnerships
April 10, 2012Research and Development CRO, partnerships
Pharma firms need to create closer and more flexible relationships with their contract research organisations for better outcomes. This is …
J&J unveils plans to boost Doxil supplies
April 10, 2012Manufacturing and Production Ben Venue, Doxil, J&J, JJ, drug shortages
Johnson & Johnson is planning to transfer filling and packaging of Doxil to another supplier in an attempt to alleviate …
Investors ramp up pressure on AZ chief
April 10, 2012Sales and Marketing AstraZeneca, David Brennan
AstraZeneca’s chief executive David Brennan is coming under increasing pressure from investors, and his future at the firm could be …
Codexis and Merck develop green Victrelis production
April 10, 2012Manufacturing and Production Codexis, Merck, manufacturing
Merck has teamed up with catalyst specialist Codexis to develop a more efficient manufacturing process for recently-approved hepatitis C treatment …
Alzheimer’s diagnostic comes with caveats
April 10, 2012Sales and Marketing Alzheimer's, Amyvid, lilly
A first-in-class test for Alzheimer’s disease has been approved by the FDA, but its makers have stressed its limitations.Lilly’s Amyvid …
Victoza superiority to Januvia made official by FDA
April 10, 2012Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes
Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …
Sheri McCoy resigns from Johnson & Johnson
April 10, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson & Johnson, Sheri McCoy, resignation
Johnson & Johnson has announced that Sheri McCoy, vice chairman of the executive committee, will leave the company on April …
Submission of labels and leaflets in the UK
April 5, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Labelling, Wainwright Associates
The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels and patient leaflets for medicinal …
Pfizer heart drug gains new licence in UK
April 5, 2012Sales and Marketing Inspra, NHS, Pfizer, heart failure
Pfizer’s heart pill Inspra has gained a new licence in the UK to reduce the risk of death in patients …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
